3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
3.3915 -0.5791 -0.0051 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3763 0.3033 0.3357 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4107 -0.2486 -0.7629 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6017 0.4223 -2.0583 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4355 -0.7472 1.4646 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0196 -0.1872 0.1616 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3529 0.2703 0.1089 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0403 0.7277 0.2808 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7926 -1.5683 0.0917 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5778 1.6424 0.1784 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2133 2.0947 0.3482 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5242 2.5523 0.2969 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8607 -2.4459 -0.0258 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1295 -1.9046 -0.0696 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0416 0.1828 -0.7789 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9560 -0.5149 0.4339 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2102 -1.9860 0.1310 H 0 0 0 0 0 0 0 0 0 0 0 0
3.5956 2.0264 0.1403 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.6005 2.8087 0.4410 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7315 3.6172 0.3489 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7038 -3.5168 -0.0802 H 0 0 0 0 0 0 0 0 0 0 0 0
4.0030 -2.5419 -0.1606 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.9066 -0.3349 -1.6436 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.6566 0.7332 -2.2542 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2147 0.2927 -2.8559 H 0 0 0 0 0 0 0 0 0 0 0 0
1 7 1 0 0 0 0
1 14 2 0 0 0 0
2 8 1 0 0 0 0
2 15 2 0 0 0 0
3 15 1 0 0 0 0
3 16 1 0 0 0 0
3 23 1 0 0 0 0
4 15 1 0 0 0 0
4 24 1 0 0 0 0
4 25 1 0 0 0 0
5 16 3 0 0 0 0
6 7 2 0 0 0 0
6 8 1 0 0 0 0
6 9 1 0 0 0 0
7 10 1 0 0 0 0
8 11 2 0 0 0 0
9 13 2 0 0 0 0
9 17 1 0 0 0 0
10 12 2 0 0 0 0
10 18 1 0 0 0 0
11 12 1 0 0 0 0
11 19 1 0 0 0 0
12 20 1 0 0 0 0
13 14 1 0 0 0 0
13 21 1 0 0 0 0
14 22 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
1-cyano-2-quinolin-5-ylguanidine
4.2 InChl
InChI=1S/C11H9N5/c12-7-15-11(13)16-10-5-1-4-9-8(10)3-2-6-14-9/h1-6H,(H3,13,15,16)
4.3 InChlKey
SKVFKJPOYOQXMA-UHFFFAOYSA-N
4.4 Canonical SMILES
C1=CC2=C(C=CC=N2)C(=C1)N=C(N)NC#N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病